Crystalline form I rosuvastatin zinc salt

The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atheros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BARTHA FERENC, SLEGEL PETER, CLEMENTIS GYOERGY, RUZSICS GYOERGY, VOLK BALAZS, HOFFMANNE FEKETE VALERIA, SZENT-KIRALLYI ZSUZSANNA, IMRE JANOS, KOVANYINE LAX GYOERGYI, NAGY KALMAN, BARKOCZY JOZSEF, KESZTHELYI ADRIENN, KRASZNAI GYOERGY, SIMIG GYULA, MOROVJAN GYOERGY, KAPUI IMRE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to crystalline Form I rosuvastatin zinc (2:1) salt, method of preparation thereof and use thereof as pharmaceutically active ingredient for the treatment of diseases related to lipid metabolism including hyperlipoproteinemia, hypercholesteremia, dyslipidemia and atherosclerosis.